在人类癌症中非编码RNA介导的糖解控制的分子概况
Sepideh Mirzaei1, Bijan Ranjbar2, Saeed Hesami Tackallou3
1Department of Biology, Faculty of Science, Islamic Azad University, Science and Research Branch, Tehran, Iran.
Pathology, research and practice
|August 3, 2023
概括
非编码RNAs (ncRNAs) 调节癌细胞糖解,影响瘤生长和治疗反应. 针对这些ncRNAs提供了作为癌症生物标志物和治疗策略的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 糖解对于癌细胞的能量生产和瘤生长至关重要.
- 抑制糖溶解可以抑制瘤的进展.
- 非编码RNAs (ncRNAs) 是癌症中糖解的关键调节者.
研究的目的:
- 阐明ncRNAs在调节癌细胞糖解中的作用.
- 探索ncRNA介导的糖解调节对瘤增殖,转移和治疗反应的影响.
- 确定ncRNAs作为癌症诊断和预后的潜在生物标志物.
主要方法:
- 关于ncRNA调节癌症中的糖解的文献综述.
- 分析微RNAs (miRNAs),长非编码RNAs (lncRNAs) 和圆形RNAs (circRNAs) 向糖解的机制.
- 研究ncRNAs在影响瘤细胞增殖,转移和对癌症疗法的反应方面的作用.
主要成果:
- ncRNAs,包括miRNAs,lncRNAs和circRNAs,显著调节癌症糖解.
- miRNAs可以禁用甘油酶并抑制信号通路.
- lncRNAs和circRNAs可以海绵miRNAs,从而控制糖解并影响瘤的进展和治疗反应.
- 通过ncRNA介导的糖解调节会影响癌症转移.
- 外体的ncRNAs显示出作为最小侵入性生物标记物的希望.
结论:
- ncRNAs是癌症糖解的关键调节者,影响瘤行为和治疗结果.
- 针对ncRNA介导的糖解路径是一个潜在的治疗策略.
- ncRNAs,特别是外体 ncRNAs,是癌症检测和监测的有价值的生物标志物.
更多相关视频
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.5K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.0K
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K